ARDSLEY ADVISORY PARTNERS LP

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 1 security · passive
Aspire Biopharma Holdings 13G/A
ASBP · 738920107
0% 5/13/2026
Event 12/31/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.